From Regulatory Challenges to Policy Recommendations: A Co-Creation Journey

On 14 July 2026, an online workshop brought together living lab practitioners from across Europe and Canada to finalise policy recommendations on regulatory barriers and enablers in transitional care. Facilitated by Francesca Sperandio and Martina Desole of the European Network of Living Labs (ENoLL) alongside Despoina Petsani, the 90-minute session invited participants to ground abstract regulatory debates in concrete experience drawn from their own projects.

📺 Missed the webinar or would like to revisit the discussion?

Watch the full recording here:

The workshop marked the culmination of several months of work. The process began with a survey distributed to living labs working in healthcare, which identified the main regulatory barriers and enabling factors encountered in practice. A first workshop then explored the concept of regulatory learning and produced initial policy recommendation ideas, which were subsequently presented during the annual regulatory learning session with the Joint Research Centre. Where earlier activities addressed transitional care in general terms, this session took a deliberately targeted approach.

Discussion was structured around three use cases: hospital discharge management and monitoring; remote monitoring and home-based care optimisation; and inclusive technologies for ageing and chronic care. Participants worked through each in turn using a shared Miro board, identifying barriers before moving to ideal solutions and finally to concrete asks for policymakers. Facilitators stressed that the use cases were not mutually exclusive, but served to give the transitional care pathway a more precise focus.

Data emerged as the dominant theme across all three use cases — specifically, questions of responsibility, liability, consent and interoperability. Janette Hughes of the Digital Health and Care Innovation Centre in Scotland described how information governance routinely delays projects, noting that applications within NHS settings can take six months to clear. Her organisation has been testing an alternative in which the patient holds their own data and grants consent to share it directly, an approach that in one carers-focused living lab saw governance signed off within days. Teemu Santonen raised the burden of repeating full approval processes for minor procedural changes, proposing pre-verified templates instead. Àlex from Neàpolis described waiting up to a year to have new devices validated in Catalonia, making fast-paced testing effectively impossible. Sara Ahmed pointed to parallel initiatives requiring duplicate data-sharing agreements, and to the persistent need to print records into patient charts for legal reasons.

A recurring proposal was the proportionality of regulation. Participants argued that requirements should reflect both technology readiness and service readiness — a text message in a discharge workflow carries different risk than continuous cardiac monitoring feeding a hospital dashboard. Several suggested living labs could act as regulatory sandboxes: trusted environments where technologies are validated at earlier stages and regulators engage with communities before rules are set. Hughes also called for dedicated innovation transfer budgets, arguing that evidence without a route into routine practice yields no impact.

ENoLL will now draft the policy recommendations from these inputs, with a validation workshop planned for September. Participants may continue contributing examples via the Miro board and the ENoLL healthcare working group. A related session will take place at Open Living Lab Days in Belgium.

From Testing to Adoption: What Makes HealthTech Solutions Ready for Real-World Deployment?

HealthTech innovation rarely fails because of a lack of ideas.
More often, it fails in the space between testing and adoption.

Many promising solutions perform well in pilot environments but struggle to scale, integrate into real healthcare settings, or gain long-term acceptance. The challenge is not proving that a technology works. The real challenge is proving that it is ready.

At EVOLVE2CARE, readiness is understood as a multi-dimensional journey, rather than just a final checkbox. Real-world deployment depends on whether solutions can respond to the practical, organisational, social, and regulatory realities of transitional care.

This blog builds on insights from Deliverable D1.2 – Stakeholder Needs Analysis and KPI Framework, which is publicly available and provides a deeper look into what makes HealthTech solutions ready for real-world deployment.

Why successful pilots don’t always lead to adoption

Testing a HealthTech solution in isolation can demonstrate technical feasibility, but real-world healthcare environments are far more complex.

Healthcare professionals operate under time pressure, fragmented systems, and strict accountability requirements. Hospitals must ensure that new solutions integrate smoothly into existing workflows without increasing workload or disrupting care delivery. Patients and caregivers need technologies that are understandable, usable, and supportive.

When these realities are not addressed early, innovations risk remaining “pilot-ready” but not system-ready.

Readiness starts with real-world relevance

A solution is ready for adoption when it demonstrates value where care actually happens.

Real-life experimentation helps innovators understand whether their solutions:

  • integrate into existing digital and organisational infrastructures
  • reduce administrative burden instead of adding complexity
  • support clinical decision-making in meaningful ways
  • improve patient experience, continuity of care, and outcomes

Living Labs play a critical role here by offering environments where innovations can be tested under realistic conditions, involving healthcare professionals, patients, caregivers, and organisations from the outset. This early exposure allows innovators to identify gaps, refine features, and adapt their solutions long before large-scale deployment.

Scaling requires more than technical performance

Moving beyond pilots requires attention to scale, sustainability, and long-term viability.

Healthcare organisations increasingly expect evidence that innovations are:

  • cost-effective and operationally efficient
  • adaptable to different care settings and regions
  • supported by training and knowledge transfer
  • aligned with broader health system goals

Regulatory preparedness as part of readiness

Regulatory compliance is often addressed late in the innovation process, creating delays and costly redesigns. However, readiness for deployment also means regulatory readiness.

Testing solutions in real-world settings helps innovators:

  • understand how regulations apply in practice
  • identify compliance challenges early
  • align development choices with safety, privacy, and legal requirements

Human-centred adoption

Readiness is ultimately about people.

Patients and caregivers have highlighted the importance of preserving human connection, clarity, and trust when digital solutions are introduced. Healthcare professionals have stressed the need for tools that support their expertise. Care organisations seek solutions that align with their operational realities.

Real-life experimentation allows these perspectives to shape innovation, ensuring that adoption is not forced, but earned through relevance and usability.

EVOLVE2CARE’s work on stakeholder needs and experimentation offers further insight into how readiness can be approached systematically across the HealthTech ecosystem. Readers interested in the methodological foundations behind this approach can further explore our public Deliverable D1.2 – Stakeholder Needs Analysis and KPI Framework.